Imunon
IMNN
25 hedge funds and large institutions have $2.28M invested in Imunon in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 11 closing their positions.
18% more call options, than puts
Call options by funds: $67K | Put options by funds: $57K
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
0.04% less ownership
Funds ownership: 0.08% → 0.04% (-0.04%)
26% less funds holding
Funds holding: 34 → 25 (-9)
39% less capital invested
Capital invested by funds: $3.76M → $2.28M (-$1.48M)
82% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
+$81.4K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$66.9K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$19.7K |
| 4 |
EP
Eudaimonia Partners
Winchester,
Tennessee
|
+$12.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$12.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$407K |
| 2 |
Two Sigma Advisers
New York
|
-$286K |
| 3 |
Two Sigma Investments
New York
|
-$170K |
| 4 |
Renaissance Technologies
New York
|
-$133K |
| 5 |
VF
Virtu Financial
New York
|
-$123K |
IMNN Hedge Fund Activity: Q4 2020 in Review
25 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q4 2020, worth a combined $2.28M — down 39% from $3.76M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of IMNN and 2 opened new positions — a net loss of 9 holders — while 7 trimmed existing stakes and 7 added.
The largest buyer was Squarepoint, opening a new position worth an estimated $81.4K. The largest seller was Morgan Stanley, cutting an estimated $407K.
- 25 institutional investors held Imunon (IMNN) as of Q4 2020, down from 34 in Q3 2020.
- Funds reported $2.28M of Imunon stock for Q4 2020, down 39% quarter-over-quarter.
- 2 funds opened new Imunon positions in Q4 2020 and 11 closed out, a net change of -9 holders.
- The largest Imunon buyer in Q4 2020 was Squarepoint, an estimated $81.4K added.
- The largest Imunon seller in Q4 2020 was Morgan Stanley, an estimated $407K sold.
Based on aggregated 13F filings for Q4 2020.